Reversing cardiac hypertrophy and heart failure using a cardiac targeting peptide linked to miRNA106a is a research paper published in Clinical and Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R41HL16421 (Gallicano, PI)
National Institutes of Health
Grant: R01 HL153407 (Mishra, PI)
National Institutes of Health
Grant: P30CA51008
American Heart Association
Grant: 18IPA34170394
National Institutes of Health
Grant: 3P30CA051008-16S1
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 1R41HL164212-01
Using Cardiac Targeting Peptide to deliver miRNA for molecular reversal of heart failure
Fields of Study
Keywords